Home/Filings/4/0001209191-22-009834
4//SEC Filing

First David 4

Accession 0001209191-22-009834

CIK 0001604477other

Filed

Feb 14, 7:00 PM ET

Accepted

Feb 15, 5:15 PM ET

Size

5.4 KB

Accession

0001209191-22-009834

Insider Transaction Report

Form 4
Period: 2022-02-10
First David
Chief People Officer
Transactions
  • Award

    Stock Option

    2022-02-10+66,00066,000 total
    Exercise: $6.57Exp: 2032-02-09Common Stock (66,000 underlying)
Footnotes (1)
  • [F1]The option vests and becomes exercisable as to 25% of the underlying securities on February 10, 2023 and in 36 substantially equal monthly installments thereafter.

Issuer

SQZ Biotechnologies Co

CIK 0001604477

Entity typeother

Related Parties

1
  • filerCIK 0001767296

Filing Metadata

Form type
4
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 5:15 PM ET
Size
5.4 KB